Literature DB >> 15580624

Effects of genetic background on cardiovascular anomalies in the Ts16 mouse.

A J Villar1, J Kim, P De Blank, A M Gillespie, H M Kozy, P C Ursell, C J Epstein.   

Abstract

To investigate the genetic contribution to phenotypic variability in aneuploidy, we generated mice with trisomy 16 (Ts16) by mating [Rb(6.16)24Lub x Rb(16.17)7Bnr]F1 males with females from four inbred strains, BALB/cJ, C3H/HeJ, C57BL/6J, and DBA/2J. Among the four Ts16 strains that were generated, there were no significant differences in survival, weight, or length relative to euploid control littermates at either embryonic day (E) 14.5 or E17.5. All Ts16 fetuses at E14.5 had edema that ranged from mild to severe, increased amniotic fluid volume, and a thickened neck. At E17.5, Ts16 fetuses exhibited two distinct phenotypes, one with an edematous morphology and the other runt-like. None of these gross morphological abnormalities was strain-specific either in occurrence or frequency. At E10.5, there were pharyngeal arch artery (PAA) anomalies in all Ts16 embryos on the C3H/HeJ background, but none in trisomics on the other three backgrounds. However, at E17.5, there was in addition to ventricular and atrioventricular septal defects, a high frequency of aortic arch defects in Ts16 fetuses, irrespective of genetic background. Taken together, these findings indicate that there are at least two mechanistic responses to the presence of three copies of mouse chromosome 16 in the modeling of the cardiovascular system: one, development of PAA defects, is strongly influenced by genetic background; but the second, development of aortic arch anomalies in the absence of preexisting PAA anomalies, is not.

Entities:  

Mesh:

Year:  2005        PMID: 15580624     DOI: 10.1002/dvdy.20216

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  4 in total

1.  Cardiovascular development and survival during gestation in the Ts65Dn mouse model for Down syndrome.

Authors:  Candice G Lorandeau; Lauren A Hakkinen; Clara S Moore
Journal:  Anat Rec (Hoboken)       Date:  2010-11-16       Impact factor: 2.064

2.  Cardiac teratogenicity in mouse maternal phenylketonuria: defining phenotype parameters and genetic background influences.

Authors:  Nikki J Seagraves; Kim L McBride
Journal:  Mol Genet Metab       Date:  2012-08-08       Impact factor: 4.797

3.  Regulator of G Protein Signaling 2 Facilitates Uterine Artery Adaptation During Pregnancy in Mice.

Authors:  Jennifer N Koch; Shelby A Dahlen; Elizabeth A Owens; Patrick Osei-Owusu
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

Review 4.  The power of comparative and developmental studies for mouse models of Down syndrome.

Authors:  Clara S Moore; Randall J Roper
Journal:  Mamm Genome       Date:  2007-07-26       Impact factor: 2.957

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.